Women's health

Risk of diabetes and cardiovascular diseases in women with pregnancies complicated by vaginal bleeding - Danish population-based cohort study

Women's mortality following a childbirth affected by vaginal bleeding

Women's mortality following a childbirth affected by vaginal bleeding

Long-term risk of cancer following pregnancies complicated by vaginal bleeding

Having a VB-affected pregnancy ending in a delivery was not associated with an increased women’s risk of cancer in comparison with having a VB-unaffected pregnancy ending in a delivery, termination or miscarriage.

Vaginal bleeding in pregnancy and women's risk of diabetes and cardiovascular diseases

Risk of diabetes and cardiovascular diseases in women with pregnancies complicated by vaginal bleeding - Danish population-based cohort study

Women’s risks of diabetes types 1 and 2 and multiple cardiovascular outcomes were increased on the relative scale following childbirths affected by VB within 20 gestational weeks when compared with VB-unaffected childbirths and terminations, but not …

Postpartum Hemorrhage As a Marker of Cancer

Abstract The association between carcinogenesis and subsequent bleeding is established. We investigated whether postpartum hemorrhage (PPH) may be a marker of clinically unrecognized cancer in women of reproductive age. In the full population, 51 224 women comprised the PPH cohort, and 536 016 women comprised the comparison cohort.

Threatened abortion and risk of epilepsy, cerebral palsy and attention-deficit/hyperactivity disorder (ADHD) in children

Abstract Previous research revealed that children born from threatened abortion (TAB)-affected gestation are at 2-3 fold increased risk of autism spectrum disorders and developmental coordination disorder. In conventional cohort analysis, TAB-affected children had a 21-25% higher relative risk of epilepsy, attention-deficit/hyperactivity disorder (ADHD), in the first 16 years of life and 42% higher relative risk of cerebral palsy in the first 6 years of life.

Hypertensive disorders of pregnancy and utilization of antihypertensive therapies

Background Hypertensive disorders of pregnancy are associated with mortality and morbidity in offspring and mothers. Use of angiotensin-converting enzyme inhibitors (ACEi) and angiotensin II receptor blockers (ARBs) is contra indicated in pregnancy.

Hypertensive Disorders Of Pregnancy And Utilization Of Antihypertensive Therapies

LACEi or ARBs were dispensed in pregnancies with chronic hypertension (590/735, 80.3%), preeclampsia superimposed on chronic hypertension (130/735, 17.7%), and gestational hypertension (15/735, 2.0%). The utilization of ACEi or ARBs for therapy of HDP was low, but not absent.